Provider Consortium Will Try 'DIY' Solution To Generic Shortages, Pricing

18 Jan 2018

Four health care systems representing 280 hospitals, with input from the US Department of Veterans Affairs, plan to make and sell their own generic drugs, focusing on those vitally needed by hospitals, with "appropriate" pricing.

While some desperate hospitals have set up parking lot compounding shops to help with drug sourcing, a group of health care providers is taking a more substantial approach, teaming up to manufacture and sell generic drugs at cheaper prices than industry firms have been doing. In a Jan. 18 announcement, Intermountain Health Care Inc., Ascension, SSM Health and Trinity Health said they will form their own non-profit generic drug maker to address shortages and price hikes that have plagued hospitals and patients.

Utah-based, non-profit Intermountain Healthcare will lead the effort, joined by SSM and Trinity (both Catholic) and faith-based Ascension, and the...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

Start your 7-day free trial
Explore trusted news, analysis, and insights
Access comprehensive global coverage
Enjoy instant access – no credit card required

Start Free Trial

Already a subscriber?

Hikma Rides Price Gap as Novo’s Ozempic, Wegovy Costs Climb

13 Aug 2025

• By Dean Rudge

Hikma is seeing increased US demand for its generic Victoza (liraglutide) after the end of semaglutide compounding lifted prices for Novo Nordisk’s Ozempic and Wegovy. Meanwhile, the company is not for now pursuing semaglutide generics in the US or EU due to patent protection, but is targeting MENA.

Lupin Launches Generic Version Of Lilly’s Discontinued Glucagon In The US

12 Aug 2025

• By Urtė Fultinavičiūtė

Alongside biosimilars, Lupin sees injectable products as one of the key growth drivers in the US, as competition for two of its “material” drugs and proposed tariffs are looming over the firm.

Arizonans To Be Offered Up To 80% Discount On Generic Drugs

12 Aug 2025

• By Urtė Fultinavičiūtė

Arizona’s governor Katie Hobbs pointed to Trump’s One Big Beautiful Bill and other federal failures as she signed an executive order to increase access to medications in her state.

Iron Sucrose Competition Expands With Viatris and Amphastar FDA Approvals

12 Aug 2025

• By Dean Rudge

Viatris and Amphastar are expanding their complex generic portfolios with the planned launches of FDA-approved versions of Vifor Pharma/Daiichi Sankyo’s Venofer (iron sucrose). The FDA’s database also show Sandoz holds an approval for generic Venofer, though it has not disclosed launch plans.